Humanwell Healthcare (Group) Co.,Ltd.

¥19.51As of Sun 8 Nov 2026, 12:00 UTC
SSE:600079Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 0.66%
Div yield 2.46%
ROE 14.28%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.32
PE TTM 12.26
TSR TTM (5.17%)
Mkt cap ¥31.84B
ROIC 12.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
13.99%
(47.40%)
Hold 10|7|5|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.40
0.39
0.39
0.37
35.50%
21.92%
16.31%
3.48%
Revenue¥B
1.484
1.456
1.415
1.403
11.64%
8.21%
1.59%
(4.69%)
Peers (US$4.774B)
Cap (US$)
PE
4.680B
9.051x
Capital
TTM
5Y
10Y
Leveragex
0.842
0.124
0.132
EBIT/Intx
0.395
0.662
0.474
Own earn%
3.99
(30.10)
(7.94)
Sh yield%
9.64
24.16
22.38
Owners
Insiders/Inst%
5.90
45.52
Short interest%
1.38
SBC / revenue%
5.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–26
$1 testx
0.0
Incr. ROIC%
14